Statement of Principles concerning polyarteritis nodosa No. 158 of 1996

Administered by Department of Veterans' Affairs

Legislation au F2008B00086 Not in force Legislative Instrument

Legislation content

Instrument No.158 of 1996

 

Determination

of

Statement of Principles

concerning

POLYARTERITIS NODOSA

ICD CODE: 446.0

 

Veterans’ Entitlements Act 1986

 

 

1. This Statement of Principles is determined by the Repatriation Medical Authority under subsection 196B(3) of the Veterans’ Entitlements Act 1986 (the Act).

 

Kind of injury, disease or death

2. (a) This Statement of Principles is about polyarteritis nodosa and death from polyarteritis nodosa.

 

 (b) For the purposes of this Statement of Principles, “polyarteritis nodosa” means a systemic necrotising vasculitis which includes classic polyarteritis nodosa, microscopic polyangiitis, Churg-Strauss syndrome and polyangiitis overlap syndrome, attracting ICD code 446.0.

 

Basis for determining the factors

3. On the sound medical-scientific evidence available, the Repatriation Medical Authority is of the view that it is more probable than not that polyarteritis nodosa and death from polyarteritis nodosa can be related to relevant service rendered by veterans or members of the Forces.

 

Factors that must be related to service

4. Subject to clause 6, the factors set out in at least one of the paragraphs in clause 5 must be related to any relevant service rendered by the person.

 

Factors

5. The factors that must exist before it can be said that, on the balance of probabilities, polyarteritis nodosa or death from polyarteritis nodosa is connected with the circumstances of a person’s relevant service are:

 

(a) for classic polyarteritis nodosa and microscopic polyangiitis only, evidence of infection with hepatitis B before the clinical onset of polyarteritis nodosa; or

 

(b) inability to obtain appropriate clinical management for polyarteritis nodosa.

 

Factors that apply only to material contribution or aggravation

6. Paragraph 5(b) apply only to material contribution to, or aggravation of, polyarteritis nodosa where the person’s polyarteritis nodosa was suffered or contracted before or during (but not arising out of) the person’s relevant service; paragraph 8(1)(e), 9(1)(e) or 70(5)(d) of the Act refers.

 

Other definitions

7. For the purposes of this Statement of Principles:

 

“classic polyarteritis nodosa” means a systemic necrotising vasculitis characterised by necrotising inflammation of medium-sized or small arteries without glomerulonephritis or vasculitis in arterioles, capillaries or venules;

 

“evidence of infection with hepatitis B” means evidence of such on serological testing, that is, evidence of hepatitis B surface antigen (HBsAg), hepatitis B e antigen, hepatitis B core antibody and/or hepatitis B surface antibody, attracting ICD code 070.2 or 070.3;

 

“ICD code” means a number assigned to a particular kind of injury or disease in the Australian Version of The International Classification of Diseases, 9th revision, Clinical Modification (ICD-9-CM), effective date of 1 July 1996, copyrighted by the National Coding Centre, Faculty of Health Sciences, University of Sydney, NSW, and having ISBN 0 642 24447 2;

 


“microscopic polyangiitis” also known as microscopic polyarteritis means a systemic necrotising vasculitis characterised by necrotising vasculitis, with few or no immune deposits, affecting small vessels (that is, capillaries, venules or arterioles).  Necrotising arteritis involving small and medium sized arteries may be present.  Necrotising glomerulonephritis is very common.  Pulmonary capillaritis often occurs;

 

“relevant service” means:

 

(a) eligible war service (other than operational service); or

(b) defence service (other than hazardous service);

 

 

Dated this Ninth day of  December  1996

 

 

The Common Seal of the    )

Repatriation Medical Authority   )

was affixed to this instrument  )

in the presence of    )

 

KEN DONALD

CHAIRMAN

 

 

 

Overview

The Determination of Statement of Principles concerning Polyarteritis Nodosa, enacted in 1996, addresses the problem of ensuring that veterans and members of the Australian Defence Force (ADF) who have contracted polyarteritis nodosa, a systemic necrotising vasculitis, are appropriately recognised and compensated under the Veterans’ Entitlements Act 1986. This legislative instrument was determined by the Repatriation Medical Authority, reflecting the policy objective to provide a clear and comprehensive framework for the recognition of this condition as service-related. The determination outlines specific factors that must exist for polyarteritis nodosa or death from the condition to be connected with the circumstances of a person’s service, including evidence of hepatitis B infection prior to the onset of the disease or the inability to obtain appropriate clinical management. The instrument aims to facilitate the assessment and compensation processes for affected veterans by establishing a definitive link between their service and the onset or aggravation of polyarteritis nodosa.

Scope and Application

The Statement of Principles concerning polyarteritis nodosa under the Veterans' Entitlements Act 1986 applies specifically to veterans and members of the Australian Defence Force who have served in relevant capacities. The conditions outlined, including classic polyarteritis nodosa, microscopic polyangiitis, Churg-Strauss syndrome, and polyarteritis overlap syndrome, are covered under ICD code 446.0. The Act stipulates that polyarteritis nodosa and death from the condition can be related to relevant service rendered by veterans if there is evidence of infection with hepatitis B before the onset of the disease or an inability to obtain appropriate clinical management for the condition. The determination applies to service rendered in eligible war service or defence service, excluding operational or hazardous service. The scope of the legislation is national, as it pertains to the Commonwealth's responsibility for veterans’ entitlements. The Act does not explicitly exclude any particular groups or conditions but focuses on the nexus between the specified diseases and relevant military service. Subordinate instruments may further define or refine the application of these principles.

Key Provisions

The Statement of Principles concerning polyarteritis nodosa, as determined under subsection 196B(3) of the Veterans' Entitlements Act 1986, establishes that polyarteritis nodosa, including its various forms such as classic polyarteritis nodosa, microscopic polyangiitis, Churg-Strauss syndrome, and polyangiitis overlap syndrome, can be related to relevant service rendered by veterans or members of the forces (Clause 2). This determination is based on sound medical-scientific evidence, which suggests that it is more probable than not that the condition or death from polyarteritis nodosa can be connected to the service (Clause 3). The Statement of Principles identifies specific factors that must be related to the relevant service, such as evidence of infection with hepatitis B prior to the onset of the condition, or the inability to obtain appropriate clinical management for polyarteritis nodosa (Clauses 4 and 5). The obligations imposed by this Statement of Principles require that any claim for benefits related to polyarteritis nodosa must demonstrate that at least one of the specified factors is connected to the veteran’s or member’s relevant service. For classic polyarteritis nodosa and microscopic polyangiitis, evidence of a hepatitis B infection before the clinical onset of the condition must be provided. Alternatively, if the polyarteritis nodosa was suffered or contracted before or during service, the inability to obtain appropriate clinical management must be established (Clause 5). Additionally, for cases where the condition predates service, the inability to obtain appropriate clinical management can contribute to or aggravate the condition, provided certain conditions are met (Clause 6). Breach of the obligations or failure to comply with the requirements of this Statement of Principles does not directly establish specific offences, penalties, or consequences within the legislative text. However, any claims for benefits related to polyarteritis nodosa that do not meet the criteria outlined in this Statement of Principles may be denied. The Veterans’ Entitlements Act 1986, under which this Statement of Principles is issued, provides a framework for the administration of veterans' benefits and includes provisions for the review and appeal of decisions related to entitlements. Failure to adhere to the conditions specified in this Statement of Principles could lead to the rejection of a claim for benefits, with potential recourse to internal review or judicial review available to the claimant under the Act.

Legal classification tags

Area of Law
Veterans’ Entitlements Law
Instrument
Legislative Instrument
Concepts
Definitions & Interpretation
Prohibited Conduct
Regulatory Standards

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.